Probiotics in Women With Primary Dysmenorrhoea

NCT04119011 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2021-02-23

No results posted yet for this study

Summary

This study compares the effect of probiotics versus placebo in women with primary dysmenorrhoea

Conditions

  • Primary Dysmenorrhea

Interventions

BIOLOGICAL

Probiotic

(Lactobacillus acidophilus, lactobacillus casei, lactobacillus lactis) and Bifidobacterium (Bifidobacterium bifidum, bifidobacterium longum, bifidobacterium infantis) lactose, sugar, milk powder, oligosaccharides, ascorbic acid, citric acid, maltodextrin, and orange flavor

OTHER

Placebo

lactose, sugar, milk powder, oligosaccharides, ascorbic acid, citric acid, maltodextrin, and orange flavor

Sponsors & Collaborators

  • B-Crobes Marketing(M) Sdn Bhd

    collaborator UNKNOWN
  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Nur Azurah Abd Ghani · National University of Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04119011 on ClinicalTrials.gov